Physician profile
Morgan D Ford
NPI 1114925286
$7,664.07
in general payments reported to CMS, 2019-2025
62 companies · $1,137 in 2025
The $1,137 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,355 · 2020: $958 · 2021: $1,523 · 2022: $1,110 · 2023: $798 · 2024: $783 · 2025: $1,137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,718.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,125.12 | 2019-2025 | |
| Pfizer INC. | $930.56 | 2019-2025 | |
| Glaxosmithkline, LLC. | $721.89 | 2019-2023 | Shingrix, Arexvy |
| Amgen INC. | $555.77 | 2019-2025 | Evenity, Krystexxa, Repatha |
| Novo Nordisk INC | $383.25 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $294.70 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $254.10 | 2019-2023 | Mounjaro |
| Novartis Pharmaceuticals Corporation | $227.69 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.70 | 2019-2025 | Jardiance |
| Exact Sciences Corporation | $188.46 | 2023-2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $169.16 | 2019-2022 | |
| Amarin Pharma, INC. | $161.36 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $157.21 | 2019-2022 | |
| Allergan, INC. | $140.55 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $136.91 | 2019-2025 | Rotateq, Capvaxive, Gardasil 9 |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.